Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. (PCSA) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 143 transactions totaling $11.3M, demonstrating a bearish sentiment with -$9.7M in net insider flow. The most recent transaction on Jan 1, 2026 involved a transaction of 249 shares valued at $0.
PCSA Insider Activity Summary
Who Is Buying PCSA Stock?
No significant insider buying has been recorded for PCSA in the recent period.
Who Is Selling PCSA Stock?
No significant insider selling has been recorded for PCSA in the recent period.
Is Processa Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PCSA is bearish with an Insider Alignment Score of 7/100 and a net flow of -$9.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PCSA Frequently Asked Questions
Understanding PCSA Insider Activity
Insider trading at Processa Pharmaceuticals, Inc. (PCSA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading PCSA stock, having executed 143 transactions in the past 90 days. The most active insider is James E. Besser (Executive), who has made 13 transactions totaling $10.4M.
Related Tools
Track Processa Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at PCSA file new Form 4 transactions